Grant Froese
CIK: 0002113261
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HELP
Helus Pharma Inc.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
About Froese Grant
Froese Grant (SEC CIK 0002113261) files insider reports with the SEC as Director of Helus Pharma Inc. (HELP).
Signal8 holds 1 ownership filing by Froese Grant, a Form 3, filed on Oct 23, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Froese Grant's filings is in TORONTO.
Other insiders filing for Helus Pharma Inc. (HELP)
- Durgam Suresh K., Director
- Lewis-Hall Freda C, Director
- Inamdar Amir, Director
- Hoskins Eric, Director
- Lawson Mark, Director
- Firestone Theresa, Director